Skip to main content
. 2019 Sep 26;40(12):1545–1556. doi: 10.1093/carcin/bgz155

Figure 6.

Figure 6.

SFN-BSE administration did not alter plasma levels of lactate or pyruvate in a clinical study. Basal and post-SFN-BSE treatment plasma levels of lactate (A) and pyruvate (B). (C) A cartoon summarizing mechanistic effects of SFN in prostate cancer cells (22,23,25–27,41,42).